AP
TMO icon

Appleton Partners’s Thermo Fisher Scientific TMO Stock Holding History

Appleton Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.78M Sell
11,519
-2,164
-16% -$1.04M 0.35% 70
2026
Q1 		$6.72M Sell
13,683
-1,215
-8% -$659K 0.47% 66
2025
Q4 		$8.63M Sell
14,898
-385
-3% -$218K 0.57% 60
2025
Q3 		$7.41M Sell
15,283
-19,229
-56% -$8.95M 0.5% 65
2025
Q2 		$14M Sell
34,512
-1,365
-4% -$571K 0.99% 28
2025
Q1 		$17.9M Sell
35,877
-271
-0.7% -$147K 1.38% 16
2024
Q4 		$18.8M Sell
36,148
-493
-1% -$271K 1.39% 14
2024
Q3 		$22.7M Sell
36,641
-524
-1% -$310K 1.67% 12
2024
Q2 		$20.6M Sell
37,165
-549
-1% -$315K 1.58% 13
2024
Q1 		$21.9M Sell
37,714
-2,716
-7% -$1.52M 1.7% 13
2023
Q4 		$21.5M Sell
40,430
-198
-0.5% -$95.8K 1.73% 12
2023
Q3 		$20.6M Sell
40,628
-987
-2% -$526K 1.83% 11
2023
Q2 		$21.7M Sell
41,615
-2,107
-5% -$1.14M 1.83% 10
2023
Q1 		$25.2M Sell
43,722
-1,436
-3% -$809K 2.24% 7
2022
Q4 		$24.9M Sell
45,158
-728
-2% -$386K 2.36% 7
2022
Q3 		$23.3M Sell
45,886
-1,246
-3% -$697K 2.33% 7
2022
Q2 		$25.6M Sell
47,132
-21
-0% -$11.6K 2.42% 6
2022
Q1 		$27.9M Sell
47,153
-1,730
-4% -$994K 2.28% 7
2021
Q4 		$32.6M Sell
48,883
-481
-1% -$300K 2.46% 7
2021
Q3 		$28.2M Sell
49,364
-761
-2% -$418K 2.35% 7
2021
Q2 		$25.3M Sell
50,125
-1,301
-3% -$614K 2.15% 9
2021
Q1 		$23.5M Sell
51,426
-671
-1% -$320K 2.18% 10
2020
Q4 		$24.3M Sell
52,097
-687
-1% -$322K 2.39% 8
2020
Q3 		$23.3M Sell
52,784
-353
-0.7% -$146K 2.57% 8
2020
Q2 		$19.3M Sell
53,137
-983
-2% -$329K 2.31% 9
2020
Q1 		$15.3M Sell
54,120
-638
-1% -$201K 2.13% 9
2019
Q4 		$17.8M Buy
54,758
+616
+1% +$187K 1.95% 9
2019
Q3 		$15.8M Buy
54,142
+532
+1% +$152K 1.9% 9
2019
Q2 		$15.7M Buy
53,610
+1,642
+3% +$452K 1.95% 9
2019
Q1 		$14.2M Sell
51,968
-594
-1% -$148K 1.89% 9
2018
Q4 		$11.8M Buy
52,562
+1,490
+3% +$350K 1.76% 11
2018
Q3 		$12.5M Sell
51,072
-886
-2% -$204K 1.66% 10
2018
Q2 		$10.8M Sell
51,958
-179
-0.3% -$38K 1.54% 11
2018
Q1 		$10.8M Sell
52,137
-276
-0.5% -$57.9K 1.63% 9
2017
Q4 		$9.95M Buy
52,413
+463
+0.9% +$88.7K 1.54% 9
2017
Q3 		$9.83M Sell
51,950
-625
-1% -$113K 1.66% 9
2017
Q2 		$9.17M Sell
52,575
-687
-1% -$115K 1.54% 10
2017
Q1 		$8.18M Sell
53,262
-6,740
-11% -$1.03M 1.51% 11
2016
Q4 		$8.47M Sell
60,002
-3,473
-5% -$512K 1.71% 8
2016
Q3 		$10.1M Sell
63,475
-2,721
-4% -$419K 1.9% 6
2016
Q2 		$9.78M Sell
66,196
-1,396
-2% -$206K 2% 6
2016
Q1 		$9.57M Buy
67,592
+533
+0.8% +$71.4K 1.89% 8
2015
Q4 		$9.51M Buy
67,059
+1,014
+2% +$135K 1.88% 7
2015
Q3 		$8.08M Buy
66,045
+558
+0.9% +$72.7K 1.84% 10
2015
Q2 		$8.5M Sell
65,487
-25
-0% -$3.26K 1.9% 10
2015
Q1 		$8.8M Buy
65,512
+2,429
+4% +$313K 1.98% 8
2014
Q4 		$7.9M Buy
63,083
+4,306
+7% +$524K 1.81% 12
2014
Q3 		$7.15M Buy
58,777
+53,787
+1,078% +$6.54M 1.67% 15
2014
Q2 		$589K Buy
4,990
+738
+17% +$86.9K 0.14% 112
2014
Q1 		$511K Hold
4,252
– – 0.12% 115
2013
Q4 		$473K Hold
4,252
– – 0.11% 108
2013
Q3 		$392K Hold
4,252
– – 0.11% 110
2013
Q2 		$360K Buy
+4,252
New +$354K 0.1% 105

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Appleton Partners's TMO Position: Q2 2026 in Review

Appleton Partners reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, selling an estimated $1.04M and leaving 11,519 shares worth $5.78M. The position accounts for 0.35% of the portfolio, ranked #70.

Appleton Partners first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $32.6M in Q4 2021. 598 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Appleton Partners held 11,519 shares of Thermo Fisher Scientific worth $5.78M as of Q2 2026.
  • Appleton Partners sold 2,164 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.04M.
  • Thermo Fisher Scientific made up 0.35% of Appleton Partners's portfolio in Q2 2026, its #70 holding.
  • Appleton Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Appleton Partners's Thermo Fisher Scientific position peaked at $32.6M in Q4 2021.
  • 598 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Appleton Partners's 13F filing for Q2 2026, filed 21 Jul 2026.